MKI67 and gastric cancer: Additionally, the combined HR from a fixed-effects model showed that a high Ki-67/MKI67 expression was also significantly connected with OS in patients with advanced GC (HR: 1.37, 95% CI: 1.18-1.60, P<0.0001; I2=0, P=0.436; Fig. 3c).